Abstract
Retinoids, such as all-trans-retinoic acid (RA), have found applications in several different types of (cancer) therapies. The synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437 or AHPN), an RA receptor (RAR)γ agonist, not only induces RARγ-dependent differentiation, but in contrast to RA, it also induces RARγ-independent apoptosis in many tumor cells. This observation makes this and similar new retinoids very interesting from a clinical perspective. Several genes have been associated with CD437/AHPN-mediated apoptosis, but the multiple activities of this compound and the apparent cell-type-specific responses to treatment have made it difficult to discern a common biochemical basis for the mechanism of its apoptotic action. In this brief review, we present a model which links all CD437/AHPN-associated apoptotic effects. CD437/AHPN rapidly induces DNA adduct formation through an as-yet unknown reaction which is independent of cell type. This is followed by a cell-type-specific, largely p53-independent DNA damage response which can result in engagement of multiple cell death pathways and activation of caspases as a common endpoint. At the same time, the RARγ-dependent pathway leads to regulation of differentiation-associated, cell-type-specific genes. CD437/AHPN, with its simultaneous differentiation and apoptosis-inducing activities, is a good prototype for new drugs which may be clinically more efficacious than those with a single activity.
Similar content being viewed by others
References
Adrain C, Martin SJ. The mitochondrial apoptosome: A killer unleashed by the cytochrome seas. Trends Biochem Sci 26:390–397;2001.
Adachi H, Adams A, Hughes FM, Zhang J, Cidlowski JA, Jetten AM. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways. Cell Death Differ 5:973–983;1998.
Adachi H, Preston G, Harvat B, Dawson MI, Jetten AM. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am J Respir Cell Mol Biol 18:323–333;1998.
Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922;1991.
Benner SE, Lippman SM, Hong WK. Current status of retinoid chemoprovention of lung cancer. Oncology 9:205–210;1995.
Bernard BA, Bernardon JM, Delescluse C, Martin B, Lenoir MC, Maignan J, Charpentier B, Pilgrim WR, Reichert U, Shroot B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. Biochem Biophys Res Commun 186:977–983;1992.
Brady HJ, Gil-Gomez G. Bax. The pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol 30:647–650;1998.
Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10:940–954;1996.
Costa SL, Paillaud E, Fages C, Rochette-Egly C, Plassat JL, Jouault H, Perzelova A, Tardy M: Effects of a novel synthetic retinoid on malignant glioma in vitro: Inhibition of cell proliferation, induction of apoptosis and differentiation. Eur J Cancer 37:520–530;2001.
Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1–11;1999.
Ding HF, Fisher DE. p53, caspase 8, and regulation of apoptosis after ionizing radiation. J Pediatr Hematol Oncol 23:185–188;2001.
Fisher DE. The p53 tumor suppressor: Critical regulator of life & death in cancer. Apoptosis 6:7–15;2001.
Fontana JA, Dawson MI, Leid M, Rishi AK, Zhang Y, Hsu CA, Lu JS, Peterson VJ, Jong L, Hobbs P, Chao WR, Shroot B, Reichert U. Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis. Int J Cancer 86:474–479;2000.
Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordonez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid. Oncol Res 10:313–324;1998.
Formelli FJ, Cleris L. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res 53:5374–5376;1993.
Gardner DG, Chen S. Retinoids and cell growth in the cardiovascular system. Life Sci 65:1607–1613;1999.
Giguere V. RA receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endocr Rev 15:61–79;1994.
Gottlieb RA. Mitochondria and apoptosis. Biol Signals Recept 10:147–161;2001.
Guan B, Yue P, Clayman GL, Sun SY. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J Cell Physiol 188:98–105;2001.
Gu Z, Flemington C, Chittenden T, Zambetti GP. ei24, a p53 response gene involved in growth suppression and apoptosis. Mol Cell Biol 20:233–241;2000.
Hail N Jr, Lotan R. Synthetic retinoid CD437/AHPN promotes rapid apoptosis in malignant human epidermal keratinocytes and G1 arrest in their normal counterparts. J Cell Physiol 186:24–34;2001.
Hail N Jr, Youssef EM, Lotan R. Evidence supporting a role for mitochondrial respiration in apoptosis induction by the synthetic retinoid CD437/AHPN. Cancer Res 61:6698–6702;2001.
Ham J, Eilers A, Whitfield J, Neame SJ, Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem Pharmacol 60:1015–1021;2000.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387–400;1995.
Hazel TG, Nathans D, Lau LF. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 85:8444–8448;1988.
Hsu SL, Yin SC, Liu MC, Reichert U, Ho WL. Involvement of cyclin-dependent kinase activities in CD437/AHPN-induced apoptosis. Exp Cell Res 252:332–341;1999.
Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC, Fontana JA. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89:4470–4479;1997.
Jehn BM, Osborne BA. Gene regulation associated with apoptosis. Crit Rev Eukaryot Gene Expr 7:179–193;1997.
Kang DC, Motwani M, Fisher PB. Role of the transcription factor AP-1 in melanoma differentiation. Int J Oncol 13:1117–1126;1998.
Lehar SM, Nacht M, Jacks T, Vater CA, Chittenden T, Guild BC. Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells. Oncogene 12:1181–1187;1996.
Leppa S, Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18:6158–6162;1999.
Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin BZ, Chen GQ, Lu JS, Lin F, Xie ZH, Fontana JA, Reed JC, Zhang XK. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289:1159–1164;2000.
Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D, Zhang XK. Molecular determinants of AHPN (CD437/AHPN)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol 18:4719–4731;1998.
Liang JY, Fontana JA, Rao JN, Ordonez JV, Dawson MI, Shroot B, Wilber JF, Feng P. Synthetic retinoid CD437/AHPN induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate 38:228–236;1999.
Lu S, Hoestje SM, Choo EM, Epner DE. Methionine restriction induces apoptosis of prostate cancer cells via the c-Jun N-terminal kinase-mediated signaling pathway. Cancer Lett 179:51–58;2002.
Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Mereau-Richard C, Costantini P, Metivier D, Susin SA, Kroemer G, Formstecher P. The novel retinoid 6-[3-1-(adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res 59:6257–6266;1999.
Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M, Garattini E. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437/AHPN) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood 93:1045–1061;1999.
Morriss-Kay GM, Ward SJ. Retinoids and mammalian development. Int Rev Cytol 188:73–131;1999.
Niederreither K, Vermot J, Messaddeq N, Schuhbaur B, Chambon P, Dolle P. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 128:1019–1031;2001.
Oridate N, Higuchi M, Suzuki S, Shroot B, Hong WK, Lotan R. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphtalene carboxylic acid (CD437/AHPN). Int J Cancer 70:484–487;1997.
Ponzanelli I, Gianni M, Giavazzi R, Garofalo A, Nicoletti I, Reichert U, Erba E, Rambaldi A, Terao M, Garattini E. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid. Blood 95:2672–2682;2000.
Prakash P, Krinsky NI, Russell RM. Retinoids, carotenoids, and human breast cancer cell cultures: A review of differential effects. Nutr Rev 58:170–176;2000.
Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Stuting S, von Stebut E, Worm M, Makki A, Jurgovsky K, Kolde G, Henz BM. Treatment of melanoma cells with the synthetic retinoid CD437/AHPN induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 135:1889–1898;1996.
Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493–504;1995.
Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol 10:839–864;1992.
Sun SY, Yue P, Chen X, Hong WK, Lotan R. The synthetic retinoid CD437/AHPN selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Cancer Res 62:2430–2436;2002.
Sun SY, Yue P, Lotan R. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437/AHPN in human prostate carcinoma cells. Oncogene 19:4513–4522;2000.
Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437/AHPN in human lung cancer cells. Cancer Res 59:2829–2833;1999.
Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Mechanisms of apoptosis induced by the synthetic retinoid CD437/AHPN in human non-small cell lung carcinoma cells. Oncogene 18:2357–2365;1999.
Sun SY, Yue P, Shroot B, Hong WK, Lotan R. Implication of c-Myc in apoptosis induced by the retinoid CD437/AHPN in human lung carcinoma cells. Oncogene 18:3894–3901;1999.
Sun SY, Yue P, Shroot B, Hong WK, Lotan R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437/AHPN. J Cell Physiol 173:279–284;1997.
Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 57:4931–4939;1997.
Wan X, Duncan MD, Nass P, Harmon JW. Synthetic retinoid CD437/AHPN induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway. Anticancer Res 21:2657–2663;2001.
Wanner R, Henseleit-Walter U, Wittig B, Kolde G. Proliferation-dependent induction of apoptosis by the retinoid CD437/AHPN in p53-mutated keratinocytes. J Mol Med 80:61–67;2002.
Wang H, Ikeda S, Kanno A, Guang LM, Ohnishi M, Sasaki M, Kobayashi T, Tamura S. Activation of c-Jun amino-terminal kinase is required for retinoic acid-induced neural differentiation of P19 embryondal carcinoma cells. FEBS Lett 503:91–96;2001.
Wu GS, Kim K, el-Deiry WS. KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Adv Exp Med Biol 465:143–151;2000.
Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437/AHPN in human leukemia HL-60 cells. Cell Death Differ 8:477–485;2001.
Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson M, Poirer G, Fontana JA. Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid. Exp Cell Res 247:233–240;1999.
Zhang J, DeYoung A, Kasler HG, Kabra NH, Kuang AA, Diehl G, Sohn SJ, Bishop C, Winoto A. Receptor-mediated apoptosis in T lymphocytes. Cold Spring Harb Symp Quant Biol 64:363–371;1999.
Zhao X, Demary K, Wong L, Vaziri C, McKenzie AB, Eberlein TJ, Spanjaard RA. Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437/AHPN (AHPN). Cell Death Differ 8:878–886;2001.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhao, X., Spanjaard, R.A. The apoptotic action of the retinoid CD437/AHPN: Diverse effects, common basis. J Biomed Sci 10, 44–49 (2003). https://doi.org/10.1007/BF02255996
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02255996